← American Medical Association
FDANonrulemakingFDA-2018-D-1067

Evaluation of Bulk Drug Substances Nominated for Use in Compounding Under Section 503B of the Federal Food, Drug, and Cosmetic Act

RIN
—
Last modified
Sep 7, 2022
Comment window
closed 3086d ago
American Medical Association filings
1

Activity

American Medical Association filed 1 comment on this docket between May 23, 2018 and May 23, 2018. 2 other organizations filed here. The comment window closed 3086d ago.

What American Medical Association filed (1)

May 23, 2018· Comment from American Medical Association· FDA-2018-D-1067-0030

Filed on regulations.gov — full text not in the inline record.

Abstract

No abstract recorded.

View on regulations.gov →
Evaluation of Bulk Drug Substances Nominated for Use in Compounding Under Section 503B of the Federal Food, Drug, and Cosmetic Act (FDA) — American Medical Association | OpenPolis